PETALING JAYA: Sinovac Covid-19 vaccines (SV) are expected to boost Pharmaniaga Bhd
’s earnings in the coming quarters mainly from the private sector and exports.
CGS-CIMB Research has raised its financial year 2021 (FY21) forecast on Pharmaniaga earnings by 4% and another 3% in FY22.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
